ANG Lifesciences India Limited (ANG.BO)
INR 26.31
(-2.01%)
INR 26.31
(-2.01%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.46 Billion INR | -33.52% |
| 2022 | 2.19 Billion INR | -37.94% |
| 2021 | 3.54 Billion INR | 130.1% |
| 2020 | 1.53 Billion INR | 21.4% |
| 2019 | 1.26 Billion INR | 4.2% |
| 2018 | 1.21 Billion INR | 59.99% |
| 2017 | 760.44 Million INR | 12.38% |
| 2016 | 676.65 Million INR | 23.2% |
| 2015 | 549.23 Million INR | 49.08% |
| 2014 | 368.41 Million INR | 6.79% |
| 2013 | 344.99 Million INR | 112.32% |
| 2012 | 162.49 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 184.1 Million INR | -51.35% |
| 2023 Q1 | 564.62 Million INR | 43.58% |
| 2023 Q2 | 332.61 Million INR | -41.09% |
| 2023 FY | 1.46 Billion INR | -33.52% |
| 2023 Q4 | 378.39 Million INR | 104.04% |
| 2023 Q3 | 185.45 Million INR | -44.24% |
| 2022 Q1 | 737.07 Million INR | -22.58% |
| 2022 Q2 | 598.2 Million INR | -18.84% |
| 2022 Q3 | 469.26 Million INR | -21.55% |
| 2022 Q4 | 393.24 Million INR | -16.2% |
| 2022 FY | 2.19 Billion INR | -37.94% |
| 2021 Q1 | 1.19 Billion INR | 237.08% |
| 2021 FY | 3.54 Billion INR | 130.1% |
| 2021 Q3 | 496.1 Million INR | -44.55% |
| 2021 Q4 | 952 Million INR | 91.9% |
| 2021 Q2 | 894.64 Million INR | -25.37% |
| 2020 Q1 | 430.63 Million INR | 26.28% |
| 2020 Q3 | 322.14 Million INR | -25.19% |
| 2020 Q2 | 430.63 Million INR | 0.0% |
| 2020 FY | 1.53 Billion INR | 21.4% |
| 2020 Q4 | 355.61 Million INR | 10.39% |
| 2019 FY | 1.26 Billion INR | 4.2% |
| 2019 Q3 | 341 Million INR | 16.33% |
| 2019 Q2 | 293.14 Million INR | 0.0% |
| 2019 Q4 | 341 Million INR | 0.0% |
| 2019 Q1 | 293.14 Million INR | -12.96% |
| 2018 Q2 | 271.68 Million INR | 0.0% |
| 2018 FY | 1.21 Billion INR | 59.99% |
| 2018 Q4 | 336.81 Million INR | 0.0% |
| 2018 Q3 | 336.81 Million INR | 23.97% |
| 2018 Q1 | 271.68 Million INR | -42.01% |
| 2017 FY | 760.44 Million INR | 12.38% |
| 2017 Q1 | 145.97 Million INR | -61.48% |
| 2017 Q2 | 145.97 Million INR | 0.0% |
| 2017 Q3 | 234.24 Million INR | 60.47% |
| 2017 Q4 | 468.49 Million INR | 100.0% |
| 2016 FY | 676.65 Million INR | 23.2% |
| 2016 Q4 | 378.92 Million INR | 100.0% |
| 2016 Q1 | 148.92 Million INR | 0.0% |
| 2016 Q2 | 148.92 Million INR | 0.0% |
| 2016 Q3 | 189.46 Million INR | 27.22% |
| 2015 FY | 549.23 Million INR | 49.08% |
| 2014 FY | 368.41 Million INR | 6.79% |
| 2013 FY | 344.99 Million INR | 112.32% |
| 2012 FY | 162.49 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 2.02 Billion INR | 27.699% |
| Bacil Pharma Limited | - INR | -Infinity% |
| Beryl Drugs Limited | 271.24 Million INR | -438.659% |
| Cian Healthcare Limited | 616.95 Million INR | -136.824% |
| Colinz Laboratories Limited | 70.29 Million INR | -1978.492% |
| Concord Drugs Limited | 449.24 Million INR | -225.234% |
| Deccan Health Care Limited | 597.28 Million INR | -144.621% |
| Gennex Laboratories Limited | 867.14 Million INR | -68.495% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -204.556% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -862.033% |
| Kerala Ayurveda Limited | 1.02 Billion INR | -42.774% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 52.434% |
| Mercury Laboratories Limited | 755.59 Million INR | -93.372% |
| Panchsheel Organics Limited | 1.05 Billion INR | -38.863% |
| Parmax Pharma Limited | 154.24 Million INR | -847.267% |
| Parnax Lab Limited | 1.88 Billion INR | 22.575% |
| Patidar Buildcon Limited | 2.3 Million INR | -63205.763% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -866.839% |
| Phaarmasia Limited | 305.93 Million INR | -377.587% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | -117.164% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 89.226% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -265.065% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -435.263% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 68.48% |
| Sunil Healthcare Limited | 901.91 Million INR | -61.999% |
| Syschem (India) Limited | 2.33 Billion INR | 37.435% |
| Trident Lifeline Limited | 446.28 Million INR | -227.39% |
| Transchem Limited | 4.09 Million INR | -35536.521% |
| Tyche Industries Limited | 696.83 Million INR | -109.676% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | -16.504% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -294.695% |
| Zenith Healthcare Limited | 144.71 Million INR | -909.624% |
| Zenotech Laboratories Limited | 368.08 Million INR | -296.941% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -13829.092% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | -39.316% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -7848.52% |
| MedPlus Health Services Limited | 56.24 Billion INR | 97.402% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -172.15% |
| Smruthi Organics Limited | 1.27 Billion INR | -14.467% |
| Trimurthi Limited | 42.23 Million INR | -3359.2% |
| Zenlabs Ethica Limited | 585.63 Million INR | -149.491% |
| Makers Laboratories Limited | 1.03 Billion INR | -40.811% |
| Lactose (India) Limited | 1.13 Billion INR | -28.29% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -227.533% |
| Roopa Industries Limited | 715.53 Million INR | -104.196% |
| PANJON LTD. | 125.52 Million INR | -1064.026% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 77.418% |
| Crestchem Limited | 212.56 Million INR | -587.375% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -26216.589% |
| PRAVEG LIMITED | 915.96 Million INR | -59.514% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 58.033% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | -95.929% |
| Norris Medicines Limited | 56.35 Million INR | -2492.614% |
| Denis Chem Lab Limited | 1.67 Billion INR | 12.938% |
| Veerhealth Care Limited | 142.13 Million INR | -927.971% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | -2.918% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -268.572% |
| Godavari Drugs Limited | 1.56 Billion INR | 6.765% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -130588.462% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 16.187% |
| Vivanza Biosciences Limited | 278.89 Million INR | -423.893% |
| Medi-Caps Limited | 265.63 Million INR | -450.039% |
| DECIPHER LABS LIMITED | 362.75 Million INR | -302.78% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | -16.056% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 13.963% |
| Bharat Parenterals Limited | 2.59 Billion INR | 43.676% |
| BDH Industries Limited | 858.31 Million INR | -70.23% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -1320.223% |
| Coral Laboratories Limited | 836.6 Million INR | -74.646% |
| Evoq Remedies Limited | 63.09 Million INR | -2215.893% |
| Trinity League India Limited | 2.95 Million INR | -49428.712% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 5.99% |
| Auro Laboratories Limited | 526.99 Million INR | -177.25% |